Financhill
Sell
25

XLO Quote, Financials, Valuation and Earnings

Last price:
$0.68
Seasonality move :
-27.24%
Day range:
$0.68 - $0.74
52-week range:
$0.62 - $1.70
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.03x
P/B ratio:
5.19x
Volume:
564.8K
Avg. volume:
464.6K
1-year change:
-39.29%
Market cap:
$35.7M
Revenue:
$6.3M
EPS (TTM):
-$0.66

Earnings Data

Next earnings date for XLO
--
Most recent earnings per share
-$0.11
Missed by $0.11
(Sep 30/2025)
Consensus Estimate
--
(Sep 30/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

XLO Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2026 Q1 $6.9M -- -- -- --
12/31/2025 Q4 $8M -- -- -- --
09/30/2025 Q3 $18.6M $19.1M -$0.11 -- --
08/08/2025 Q2 $8.2M $8.1M -$0.16 -- --
05/08/2025 Q1 $23.2M $2.9M -$0.18 -- --
03/11/2025 Q4 $3.3M $1.7M -$0.20 -$0.22 $0.02
11/07/2024 Q3 $3.3M $2.3M -$0.22 -$0.30 $0.08
08/08/2024 Q2 $30M $2.4M -$0.24 -$0.34 $0.10
05/14/2024 Q1 $10M -- -$0.62 -$0.28 -$0.34
03/01/2024 Q4 -- -- -$0.64 -$0.61 -$0.03
11/06/2023 Q3 -- -- -$0.61 -$0.83 $0.22
08/14/2023 Q2 -- -- -$0.70 -$0.88 $0.18
05/09/2023 Q1 -- -- -$0.83 -$0.90 $0.07
03/02/2023 Q4 -- -- -$0.82 -$0.80 -$0.02
11/09/2022 Q3 -- -- -$0.72 -$0.89 $0.17
08/09/2022 Q2 -- -- -$0.90 -$0.79 -$0.11
05/12/2022 Q1 -- -- -$0.78 -- --
03/01/2022 Q4 -- -- -$0.98 -- --
12/02/2021 Q3 -- -- -$0.61 -- --
06/30/2021 Q2 -- -- -$0.87 -- --
03/31/2021 Q1 -- -- -$0.63 -- --
12/31/2020 Q4 -- -- -$0.78 -- --
09/30/2020 Q3 -- -- -$0.56 -- --

Xilio Therapeutics, Inc. Earnings Questions

  • How Much did Xilio Therapeutics, Inc. Generate in Revenue Last Quarter?

    Xilio Therapeutics, Inc. reported $19.1M worth of top line sales in its most recent quarter.

  • Did Xilio Therapeutics, Inc. Beat Earnings Last Quarter?

    Xilio Therapeutics, Inc. announced earnings per share of -$0.11 which represents a miss of analyst forecast a -- per share.

  • Is Xilio Therapeutics, Inc. Profitable?

    Xilio Therapeutics, Inc. reported $18.7M that represents $0.13 per share over the last quarter.

  • What is the Analyst Consensus for Xilio Therapeutics, Inc. EPS Next Year?

    Xilio Therapeutics, Inc.'s earnings are forecast to decrease from -$1.09 per share to -$1.21 per share next year representing a decrease of -79.79%.

  • When is Xilio Therapeutics, Inc.'s Earnings Date?

    Currently, Xilio Therapeutics, Inc. has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on April 12, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Shopify Stock a Good Buy Now?
Is Shopify Stock a Good Buy Now?

eCommerce technology platform Shopify (NASDAQ:SHOP) delivered impressive returns in 2025…

Will The Magnificent 7 Stocks Go Up This Year?
Will The Magnificent 7 Stocks Go Up This Year?

2025 was another banner year for the Magnificent Seven stocks,…

Why Did Planet Labs Stock Rally So Much?
Why Did Planet Labs Stock Rally So Much?

Satellite imaging startup Planet Labs (NYSE:PL), after years of disappointing…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
65
Is GOOG Stock a Buy?

Market Cap: $4T
P/E Ratio: 41x

Buy
51
Is GOOGL Stock a Buy?

Market Cap: $4T
P/E Ratio: 41x

Alerts

Buy
100
ATGL alert for Jan 10

Alpha Technology Group Ltd. [ATGL] is up 47.05% over the past day.

Buy
71
NAIL alert for Jan 10

Direxion Daily Homebuilders & Supplies Bull 3X Shs [NAIL] is up 18.52% over the past day.

Buy
54
LGIH alert for Jan 10

LGI Homes, Inc. [LGIH] is up 13.81% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock